lp002
Showing 1 - 4 of 4
Digestive System Tumors Trial in China (LP002, Cisplatin, Fluorouracil)
Unknown status
- Digestive System Neoplasms
- LP002
- +3 more
-
Beijing, Beijing, China
- +5 more
Feb 12, 2021
Small-cell Lung Cancer Trial in China (LP002, Carboplatin, Etoposide)
Recruiting
- Small-cell Lung Cancer
- LP002
- +2 more
-
Zhengzhou, Henan, China
- +7 more
Feb 1, 2021
Primary Mediastinal Large B-Cell Lymphoma (PMBCL) Trial in China (LP002)
Not yet recruiting
- Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
- LP002
-
Beijing, Beijing, China
- +6 more
Oct 19, 2020